Cortagen 20 mg research peptide

Buy Cortagen 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Cortagen is a tetrapeptide associated with the sequence Ala-Glu-Asp-Pro, abbreviated AEDP.

The vial amount and container capacity describe different things: 20 mg is the labeled material amount, while 3 mL is the vial capacity. Neither specifies the concentration of a prepared solution.

Material identity and study context

Match the complete compound name and sequence to your protocol. Cortagen and Crystagen are separate named materials. A similarly named peptide or a peptide mixture is not an interchangeable specification.

In an original study by Turchaninova and colleagues, Cortagen was investigated in rats after transection and suturing of the sciatic nerve. The researchers reported increased growth rate and conduction velocity in regenerating nerve fibers under the tested conditions.

These were measurements of peripheral nerve regeneration in a defined animal model. They do not establish the same response in another tissue or assay, and they do not verify the activity of a supplied product lot. Read the original experimental method when deciding whether its material and endpoints match your research question.

Review the COA and product documents

Use the COA and documents tab to inspect available reports and handling files. Check the product name, presentation and lot before using a result in your material records.

• Identity: review the reported method and any sequence or chemical-form information required by your experiment.
• Purity and content: an HPLC purity percentage and a measured material amount answer different questions. Use the report’s own units and methods.
• Preparation: confirm the supplied chemical form before using a molecular weight in calculations. Follow the material’s documented storage and handling requirements.

If a protocol-critical specification is absent, request it before selecting the material for that experiment.